Table 1.
Mean (±SD) | Range | |
---|---|---|
(A) | ||
Age (Y) | 34.9 (±9.54) | (18; 54) |
MS duration (Y) | 9.6 (±2.91) | (4; 15) |
Post ‐treatments | n | % |
---|---|---|
Interferon b‐1 | 4 | 40 |
Interferon MXT | 4 | 40 |
Interferon Nat | 1 | 10 |
Interferon &SC | 1 | 10 |
Mean (±SD) | Range | |
---|---|---|
(B) | ||
Number of MSCs injected (×106) | 110 (±23.1) | (93; 168) |
CM volume (mL) | 18.3 (±2.79) | (13; 20) |
MXT, Mitoxantrone; Nat, Natalizumab; SC, stem cell; MSCs, mesenchymal stem cells; CM, conditioned media.